Caribou Biosciences Inc (CRBU NASDAQ) stock market data APIs
$1.7305
0.09(5.2%)
as of September 17, 2025
Try our APIs with
free plan!
Caribou Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Prev. Close
1.7305
Open
1.8214
High
1.8612
Low
1.7087
52 wk Range
0.66-2.9995
Market Cap
160 M
Shares Outstanding
93 123 K
Revenue
9 121 K
EPS
-0.35
Beta
2.545
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Caribou Biosciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Caribou Biosciences Inc data using free add-ons & libraries
Get Caribou Biosciences Inc Fundamental Data
Caribou Biosciences Inc Fundamental data includes:
- Net Revenue: 9 121 K
- EBITDA: -146 260 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Caribou Biosciences Inc News
New
August 2025's Top Penny Stocks With Growth Potential
As the U.S. stock market inches higher, with major indices nearing record highs, investors are closely watching key developments such as Nvidia's earnings report and shifts in Federal Reserve policy. ...
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference
BERKELEY, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwit...
Caribou Biosciences Inc (NASDAQ:CRBU) Posts Mixed Q2 2025 Earnings with Revenue Beat but Wider Loss
CARIBOU BIOSCIENCES INC (NASDAQ:CRBU [https://www.chartmill.com/stock/quote/CRBU]) REPORTS Q2 2025 EARNINGS: MIXED RESULTS AND MARKET REACTION Caribou Biosciences Inc (NASDAQ:CRBU [https://www.chartm...
Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates
Biogen Inc. (BIIB) came out with quarterly earnings of $5.47 per share, beating the Zacks Consensus Estimate of $3.93 per share. This compares to earnings of $5.28 per share a year ago. These figures ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
